Balyasny Asset Management
KERX

Balyasny Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Balyasny Asset Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-150,000
Closed -$698K – 2194
2017
Q4 		$698K Buy
+150,000
New +$698K ﹤0.01% 1206
2014
Q1 		– Sell
-928,464
Closed -$12M – 580
2013
Q4 		$12M Sell
928,464
-208,565
-18% -$2.7M 0.16% 142
2013
Q3 		$11.5M Buy
+1,137,029
New +$11.5M 0.15% 156